Lawmakers raised new concerns over the FDA’s ultra-rapid drug review program
2026-02-03
By MATTHEW PERRONE WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration (FDA) program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying with federal ethics rules. In a letter sent Tuesday, Representative JakeContinue Reading